Skip to main content
Home
  • Affected by Cancer
  • Healthy Living
  • Clinical Best Practice
  • Research & Data
  • Publications & Resources
  • About Us
  • Home
  • Affected by Cancer
    • What is cancer
    • Cancer A-Z
    • Cancer statistics
    • Interactive body map
    • Check your cancer risk online
    • Treatment
    • Living with cancer
    • Life after cancer
    • For Aboriginal and Torres Strait Islander people
    • Cancer support organisations
    • Australian cancer trials
    • Jeannie Ferris Award
    • COVID-19 and cancer
    • Culturally and Linguistically Diverse (CALD)
    • Bladder cancer
    • Bowel cancer
    • Brain cancer
    • Breast cancer
    • Breast cancer in men
    • Breast cancer in young women
    • Cervical cancer
    • Children's Cancer
    • Endometrial cancer
    • Fallopian cancer
    • Gestational trophoblastic disease
    • Gynaecological cancers
    • Head and neck cancer
    • Kidney cancer
    • Leukaemia
    • Liver cancer
    • Lung cancer
    • Lymphoma
    • Melanoma of the skin
    • Mesothelioma cancer
    • Myeloma
    • Neuroendocrine tumours
    • Oesophageal cancer
    • Ovarian cancer
    • Pancreatic cancer
    • Prostate cancer
    • Sarcoma
    • Stomach cancer
    • Testicular cancer
    • Thyroid cancer
    • Unknown primary
    • Uterine sarcoma
    • Vaginal cancer
    • Vulval cancer
  • Healthy Living
    • Lifestyle & risk reduction
    • Screening
  • Clinical Best Practice
    • Cancer types
    • Psychosocial care
    • Multidisciplinary care
    • Cancer learning
    • Australian cancer trials
    • Consumer engagement
    • Shared follow-up care
  • Research & Data
    • Research
    • Grants and funding
    • Support for clinical trials
    • Cancer data
  • Publications & Resources
    • Cancer Australia publications
    • Position statements
    • Clinical Practice Guidelines
    • Cancer Australia websites
    • Cancer risk online tools
    • Other tools and resources
    • Podcasts
    • Subscribe to our eNewsletter
    • Glossary
  • About Us
    • Strategic Plan 2014-2019
    • Organisational structure
    • Accountability and reporting
    • Position Statements
    • Who we work with
    • Lung Cancer Screening enquiry
    • National Pancreatic Cancer Roadmap
    • News
    • Media
    • Campaigns & events
    • Information publication scheme
    • Reconciliation action plan
    • Employment opportunities
    • Contact us

Gynaecological cancers

gynaecological-mm affected-cancer/cancer-types/gynaecological-cancer/what-are-gynaecological-cancers
    • Home
    • Types
    • Statistics
    • Risk factors
    • Symptoms
    • Screening
    • Diagnosis
    • Treatment
    • Finding support
    • Clinical trials
    • Health professionals
      • Endometrial cancer guidelines
      • Ovarian cancer guidelines
      • Ovarian cancer risk
      • Psychosexual care of women
    • Home
    • Types
    • Statistics
    • Risk factors
    • Symptoms
    • Screening
    • Diagnosis
    • Treatment
    • Finding support
    • Clinical trials
    • Health professionals
      • Endometrial cancer guidelines
      • Ovarian cancer guidelines
      • Ovarian cancer risk
      • Psychosexual care of women
  1. Home
  2. Statistics

Gynaecological cancer in Australia statistics

  • Printer-friendly version
  • A|A

The following material has been sourced from the Australian Institute of Health and Welfare

Gynaecological cancer incorporates ICD-10 cancer codes C51 (Malignant neoplasm of vulva), C52 (Malignant neoplasm of vagina), C53 (Malignant neoplasm of cervix), C54 (Malignant neoplasm of corpus uteri), C55 (Malignant neoplasm of uterus, part unspecified), C56 (Malignant neoplasm of ovary), C57 (Malignant neoplasm of other and unspecified female genital organs) and C58 (Malignant neoplasm of placenta).


Estimated number of new cases of gynaecological cancer diagnosed in 2020

female icon6,652 females


Estimated % of all new female cancer cases diagnosed in 2020

9.7%


Estimated number of deaths from gynaecological cancer in 2020

female icon2,096 females


Estimated % of all female deaths from cancer in 2020

9.4%


Chance of surviving at least 5 years (2011–2015)

70%


Females living with gynaecological cancer at the end of 2014 (diagnosed in the 5 year period 2010 to 2014)

19,871


New cases

In 2015, gynaecological cancer as a group represents 9.5% of cancers diagnosed in women and the most common gynaecological cancer was uterine cancer (see details on the uterine cancer page). 

In 2015, there were 5,661 new cases of gynaecological cancer diagnosed in Australia. In 2020, it is estimated that 6,652 new cases of gynaecological cancer will be diagnosed in Australia. In 2020, it is estimated that the risk of a female being diagnosed with gynaecological cancer by her 85th birthday will be 1 in 20. 

Figure 1. Estimated most common cancers diagnosed among females, 2020

Notes 

  • Data sourced from AIHW 2019 Cancer Data in Australia, ACIM books, and Cancer in Australia 2020 report and supplementary data tables 
  • More information about incidence rates for the most common cancers diagnosed can be found on the NCCI website in the ‘Cancer incidence’ section (https://ncci.canceraustralia.gov.au/diagnosis/cancer-incidence/cancer-incidence) 

In 2015, the age-standardised incidence rate was 41 new cases per 100,000 females. In 2019, it is estimated that the age-standardised incidence rate will be 43 cases per 100,000 females. The incidence rate for gynaecological cancer is expected to increase with age, peaking at age group 70–74. 

Figure 2. Age-standardised incidence rates for gynaecological cancer, 1982 to 2015 

Note: Data sourced from AIHW 2019 Cancer Data in Australia, ACIM books, and Cancer in Australia 2019 report and supplementary data tables 

The number of new cases of gynaecological cancer diagnosed increased from 2,951 in 1982 to 5,661 in 2015. Over the same period, the age-standardised incidence rate decreased from 44 cases per 100,000 females in 1982 to 41 cases per 100,000 females in 2015. 

Deaths 

In 2016, gynaecological cancer as a group represents 9.5% of cancer related deaths in women and ovarian cancer was the most common cause of gynaecological cancer-related death. 

In 2016, there were 1,884 deaths from gynaecological cancer in Australia. In 2020, it is estimated that there will be 2,096 deaths. In 2020, it is estimated that the risk of a female dying from gynaecological cancer by her 85th birthday will be 1 in 59. 

Figure 3. Estimated most common causes of cancer death among females, 2020

Notes 

  • Data sourced from AIHW 2019 Cancer Data in Australia, ACIM books, and Cancer in Australia 2019 report and supplementary data tables 
  • More information about mortality rates for the most common causes of cancer death can be found on the NCCI website in the ‘Cancer mortality’ section (https://ncci.canceraustralia.gov.au/outcomes/cancer-mortality/cancer-mortality) 

In 2016, the age-standardised mortality rate for gynaecological cancer was 13 deaths per 100,000 females. In 2020, it is estimated that the age-standardised mortality rate will remain at 13 deaths per 100,000 females. The mortality rate for gynaecological cancer is expected to increase with age. 

Figure 4. Age-standardised mortality rates for gynaecological cancer, 1968 to 2016 

Note: Data sourced from AIHW 2019 Cancer Data in Australia, ACIM books, and Cancer in Australia 2019 report and supplementary data tables 

The number of deaths from gynaecological cancer increased from 1,120 in 1968 to 1,884 in 2016. Over the same period, the age-standardised mortality rate decreased from 23 deaths per 100,000 females in 1968 to 13 deaths per 100,000 females in 2016. 

Survival 

In 2011–2015, females diagnosed with gynaecological cancer had a 70% chance of surviving for at least five years compared to their counterparts in the general Australian population. Between 1986–1990 and 2011–2015, the five-year relative survival from gynaecological cancer increased from 62% to 70%. 

Figure 5. 5-year relative survival from gynaecological cancer, 1986–1990 to 2011–2015 

Notes: Data sourced from AIHW 2019 Cancer Data in Australia, ACIM books, and Cancer in Australia 2019 report and supplementary data tables 

Prevalence 

At the end of 2014, there were 4,994 females living who had been diagnosed with gynaecological cancer that year, 19,871 females living who had been diagnosed with gynaecological cancer in the previous 5 years (from 2010 to 2014) and 61,208 females living who had been diagnosed with gynaecological cancer in the previous 33 years (from 1982 to 2014). 

For more information on cancer data, see the NCCI website  

The National Cancer Control Indicators (NCCI) are a set of indicators across the continuum of cancer care, from Prevention and Screening through to Diagnosis, Treatment, Psychosocial care, Research and Outcomes.  The NCCI website allows users to see visual representations of data on each indicator through interactive charts. 

  • Last Updated
  • Relevant Links
updated: 22 October 2020 - 4:17pm
Australian Cancer Research Foundation, Gynaecological cancer
Australian Cancer Trials

Related information

What is cancer?
What is cancer?

Cancer is a disease of the cells, which are the body’s basic building blocks.

Treatment and side effects
Treatment and side effects

The treatment that your doctors recommend will depend on the type of cancer you have, how advanced it is, and other personal factors.

Living with cancer
Living with cancer

A diagnosis of cancer marks the beginning of a journey full of emotional, psychological, physical and practical challenges.

Life after cancer
Life after cancer

While looking forward to finishing their cancer treatment and getting on with life, for some people, the end of treatment can also be a confusing or worrying time.

A-Z List of Cancer Types

Information on more than 70 types of cancer

  • Bladder cancer
  • Bowel cancer
  • Brain cancer
  • Breast cancer
  • Breast cancer in men
  • Breast cancer in young women
  • Cervical cancer
  • Children's Cancer
  • Endometrial cancer
  • Fallopian cancer
  • Gestational trophoblastic disease
  • Gynaecological cancers
  • Head and neck cancer
  • Kidney cancer
  • Leukaemia
  • Liver cancer
  • Lung cancer
  • Lymphoma
  • Melanoma of the skin
  • Mesothelioma cancer
  • Myeloma
  • Neuroendocrine tumours
  • Oesophageal cancer
  • Ovarian cancer
  • Pancreatic cancer
  • Prostate cancer
  • Sarcoma
  • Stomach cancer
  • Testicular cancer
  • Thyroid cancer
  • Unknown primary
  • Uterine sarcoma
  • Vaginal cancer
  • Vulval cancer

About Cancer Australia

Cancer Australia was established by the Australian Government in 2006 to benefit all Australians affected by cancer, and their families and carers. Cancer Australia aims to reduce the impact of cancer, address disparities and improve outcomes for people affected by cancer by leading and coordinating national, evidence-based interventions across the continuum of care.

If you would like an interpreter to help you understand any information on this website, please call TIS National on 131 450 and ask them to call Cancer Australia on 02 9357 9400. Our business hours are 9am to 5pm, Monday to Friday.

Freecall 1800 624 973
+61 2 9357 9400

Locked Bag 3, Strawberry Hills
NSW 2012

Navigation

  • Affected by Cancer
  • Healthy Living
  • Clinical Best Practice
  • Research & Data
  • Publications & Resources
  • About Us

Contact us

* Denotes mandatory fields
 

By submitting this form, you accept the Cancer Australia privacy policy.

  • Contact Us
  • Copyright
  • Disclaimer
  • Privacy policy
  • Sitemap
Copyright © 2021 - Cancer Australia